Changes in T-lymphocyte subsets and risk factors in human immunodeficiency virus-negative patients with active tuberculosis.

PURPOSE: Immune function imbalance is closely associated with the occurrence and development of infectious diseases. We studied the characteristics of changes in T-lymphocyte subsets and their risk factors in HIV-negative patients with active tuberculosis (ATB). METHODS: T-lymphocyte subsets in 275 HIV-negative ATB patients were quantitatively analyzed and compared with an Mycobacteriumtuberculosis-free control group. Single-factor and multifactor analyses of clinical and laboratory characteristics of patients were also conducted. RESULTS: In ATB patients, CD4 and CD8 T-cell counts decreased, and the levels were positively interrelated (r = 0.655, P < 0.0001). After 4 weeks of antituberculosis treatment, CD4 and CD8 T-cell counts increased significantly but remained lower than in the control group. CD4 and CD8 cell counts were negatively associated with the extent of lesions detected in the chest by computed tomography (all P < 0.05). Although not reflected in the CD4/CD8 ratio, CD4 and CD8 cell counts differed between drug-resistant TB patients and drug-susceptible TB patients (P = 0.030). The multivariate analysis showed prealbumin, alpha-1 globulin, body mass index, and platelet count were independent risk factors for decreased CD4 cell count (all P < 0.05), while age and platelet count were independent risk factors for decreased CD8 cell count (all P < 0.05). CONCLUSION: CD4 and CD8 T-cell counts showed the evident value in predicting ATB severity. An increase in the CD4/CD8 ratio may be a critical clue of drug resistance in ATB. Although the factors influencing CD4 and CD8 are not identical, our results indicated the importance of serum protein and platelets to ATB patients' immune function.

B-cell specific Moloney murine leukemia virus insertion site 1 contributes to invasion, metastasis, and poor prognosis in salivary adenoid cystic carcinoma.

Background/purpose: Upregulation of B-cell specific Moloney murine leukemia virus insertion site 1 (BMI-1) has been involved in the invasion, metastasis, and poor prognosis of many cancers. The aim of this study was to evaluate the levels and clinical significance of BMI-1 in saliva of patients with salivary adenoid cystic carcinoma (SACC), and to analyze biological function and mechanism of BMI-1 in the invasion and metastasis of SACC. Materials and methods: The levels of BMI-1 in saliva and tumor tissues of SACC patients were determined. The correlation of salivary BMI-1 levels with clinicopathological parameters and clinical outcomes in patients with SACC was analyzed. Additionally, the effects of BMI-1 on wound-healing, transwell invasion, and epithelial-mesenchymal transition (EMT)-related protein expression in vitro as well as on tumorigenicity and experimental lung metastasis in vivo were investigated through exogenous overexpression and silencing of BMI-1 in SACC cells. Results: BMI-1 levels increased in saliva and tumor tissues in SACC patients with invasion or metastasis. High salivary BMI-1 levels were correlated with poor TNM stage, poor overall survival, and disease-free survival. Exogenous expression of BMI-1 in SACC-83 promoted its migration and invasion, while silencing BMI-1 in SACC-LM inhibited its migration and invasion in vitro and suppressed tumorigenesis and lung metastasis in vivo. Furthermore, BMI-1 regulated the expression of EMT-related proteins in SACC. Conclusion: Our study shows that BMI-1 can serve as a valuable biomarker to identify tumor invasion and metastasis in SACC, predict its prognosis, and act as a promising therapeutic target for SACC.

Design of the offline test electronics for the nozzle system of proton therapy.

A set of nozzle equipment for proton therapy is currently under development at China Institute of Atomic Energy (CIAE). To facilitate the off-line commissioning of the whole equipment, a set of ionization chamber signal generation system, known as the test electronics, was designed. The results showed that the system can simulate the beam position, beam fluence (which exhibits a positive correlation with the dose), and other related analog signals generated by the proton beam when it traverses the ionization chamber. Moreover, the accuracy of the simulated beam position is within ± 0.33 mm, and the accuracy of the simulated beam fluence signal is within ± 1%. The test electronics can output analog signals representing environmental parameters. The test electronics meets the design requirements, which can be used for the commissioning of the nozzle system as well as the treatment control system without the presence of the proton beam.

Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.

Oral leukoplakia (OL) is the most common premalignancy in the oral cavity. The objective of this study was to investigate the biological role of transglutaminase 3 (TGM3) in malignant transformation of OL and its clinical value for predicting oral squamous cell carcinoma (OSCC) risk in patients with OL. Immunohistochemistry was used to measure TGM3 expression in OL samples from 98 patients. Patient clinicopathological and follow-up data were analyzed. The TGM3 biological role in OL cells was investigated in gain-of-function and loss-of-function assays, and the TGM3 downregulated mechanism in OLs was characterized. TGM3 mRNA and protein expressions were frequently downregulated in OL cells and samples. DNA hypermethylation was a mechanism of TGM3 downregulation. TGM3 overexpression and silencing affected the proliferation, colony formation, and apoptosis of OL cells through apoptosis-related protein dysregulations. Lower TGM3 levels were strongly associated with the grade of epithelial dysplasia and OSCC development. Multivariate analyses showed that TGM3 was the independent predictor for malignant transformation of OL. Collectively, these data indicated that TGM3 played an important role in OL malignant transformation and may serve as a predictor to identify OL with OSCC development.

[Clinical observation of assisted occlusion therapy for repositioning temporomandibular joint discs].

PURPOSE: To investigate the occurrence of postoperative malocclusion of patients with temporomandibular joint disc repositioning and the necessity of postoperative orthodontic treatment. METHODS: One hundred and eight patients who received temporomandibular joint disc repositioning from 2010.10 to 2015.10 were selected in this study. The patients' occlusion was recorded preoperatively and postoperatively. All patients received functional appliance or orthodontic treatment after surgery. The occlusion and the relative position of the articular disc and condyle were evaluated at regular follow-up. RESULTS: Postoperative malocclusion occurred in all patients. The use of functional appliance for 3-6 months may decrease the proportion of malocclusion. After orthodontic treatment, all patients had a complete recovery of malocclusion and remained good articular disc and condyle relationship during long term follow-up. CONCLUSIONS: Postoperatively malocclusion may occur after temporomandibular joint disc repositioning, and the use of functional appliance and orthodontic treatment are strongly recommended to retain good articular disc and condyle relationship.

[A preliminary study of surgical treatment for disc displacement of temporomandibular joint].

PURPOSE: To preliminarily evaluate the surgical treatment results of disc displacement of temporomandibular joint(TMJ). METHODS: From October 2009 to September 2010, 9 patients (11 joints) with disc displacement of TMJ ( 8 females and 1 male, and with an average mouth opening of 21.3mm) underwent disc repositioning and fixation via arthroscopy or open anchorage surgery. All patients were clinically followed up at least 3 months, and MRI examinations were performed at regular intervals. RESULTS: All incisions healed well and there were no severe complications. The average mouth opening increased to 32.8mm and the disc position remained favorable on MRI at the latest follow-up. CONCLUSIONS: With accurate diagnosis and selection of appropriate indications, disc repositioning and fixation via arthroscopy or open anchorage surgery should be used as a treatment of choice for disc displacement of TMJ.

Design of a compact, permanent magnet electron cyclotron resonance ion source for proton and H2(+) beam production.

A 2.45 GHz microwave ion source was developed at China Institute of Atomic Energy (CIAE) for proton beam production of over 60 mA [B.-Q. Cui, Y.-W. Bao, L.-Q. Li, W.-S. Jiang, and R.-W. Wang, Proceedings of the High Current Electron Cyclotron Resonance (ECR) Ion Source for Proton Accelerator, APAC-2001, 2001 (unpublished)]. For various proton beam applications, another 2.45 GHz microwave ion source with a compact structure is designed and will be built at CIAE as well for high current proton beam production. It is also considered to be used for the test of H(2)(+) beam, which could be injected into the central region model cyclotron at CIAE, and accelerated to 5 MeV before extraction by stripping. The required ECR magnetic field is supplied by all the permanent magnets rather than electrical solenoids and six poles. The magnetic field distribution provided by this permanent magnets configuration is a large and uniformly volume of ECR zone, with central magnetic field of a magnitude of approximately 875 Gs [T. Taylor and J. S. C. Wills, Nucl. Instrum. Methods Phys. Res. A 309, 37 (1991)]. The field adjustment at the extraction end can be implemented by moving the position of the magnet blocks. The results of plasma, coupling with 2.45 GHz microwave in the ECR zone inside the ion source are simulated by particle-in-cell code to optimize the density by adjusting the magnetic field distribution. The design configuration of the ion source will be summarized in the paper.